2019 Overview of E3 Ligases: Arvinas and Other “Rock Stars” Of UPS Drug Development Sector
- Friday, November 8, 2019, 7:10
- PR Newswire
- Add a comment
DUBLIN, Nov. 8, 2019 /PRNewswire/ — The “Nothing Degrading about Saving Lives: E3 Ligands Recruiting New Drugs” report has been added to ResearchAndMarkets.com’s offering. Posttranslational modifications hit prime time in the pharma industry. There probably isn’t a medium-sized…
About the Author
admin has written 20655 stories on this site.